BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

DiNAQOR

DiNAQOR logo

Founded
2019
Geography
Switzerland based
Funding
$125 M

DiNAQOR is a global gene therapy platform company focused on advancing novel solutions for patients suffering from heart disease. We are headquartered in Pfäffikon, Switzerland, with additional presence in London, England and Boston, Massachusetts.


Posts Mentioning This Company

Biopharma Insights

R&D Platform

Their innovation is in utilising AAV serotypes with increased specificity towards cardiac tissues together with cardiac-specific promoter which improves gene expression in the heart tissues. This could potentially lower the toxicity issues which often accompanies the gene-therapy approach. The current lead therapy DINA-001 against monogenic cardiomyopathy is in the preclinical stage.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet